A John Hopkins study suggests gaining a better understanding of physical frailty could eventually help people age more healthfully.
The National Comprehensive Cancer Network has published NCCN Guidelines for Histiocytosis.
A study led by Yale Cancer Center and Department of Neurology researchers demonstrated that a blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma.
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell therapy, to reduce the severity of treatment side effects.
City of Hope scientists have combined a checkpoint inhibitor with an anti-parasitic drug, ivermectin, to treat triple-negative breast cancer in preclinical research.
GO2 Foundation for Lung Cancer has created a multi-institutional study to determine how to improve the participation of Black communities in lung cancer clinical trials.Â
An NCI study demonstrated that people who have had evidence of a prior infection with SARS-CoV-2, the virus that causes COVID-19, appear to be well protected against being reinfected with the virus, at least for a few months.
A study conducted in spring of 2020 demonstrated that one-third of U.S. cancer survivors are worried about treatment and cancer care disruptions during the COVID-19 pandemic.
The National Comprehensive Cancer Network, American Cancer Society Cancer Action Network, and the National Minority Quality Forum have developed recommendations on how to lessen racial disparities in cancer care.
A study from researchers at University of North Carolina at Chapel Hill has found that smokers who saw messages about tobacco chemicals with associated health risks, together with graphic health images and information promoting quitting, expressed greater desire to quit smoking.
